Do guidelines preclude hepatitis B patients from receiving treatment?

Abstract

I read with great interest the work by Tong et al.1 on the evaluation of current treatment recommendations based on a longitudinal cohort of 369 chronic hepatitis B patients followed for a mean of 84 months. Under the published guidelines, in 2003-2007, 40% to 80% of patients who developed hepatocellular carcinoma (HCC) or died of liverrelated problems did… (More)
DOI: 10.1002/hep.22722

Topics

1 Figure or Table

Slides referencing similar topics